These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12794581)

  • 21. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.
    Elder DJ; Halton DE; Crew TE; Paraskeva C
    Int J Cancer; 2000 May; 86(4):553-60. PubMed ID: 10797271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 expression in the adenoma-carcinoma sequence of human gallbladder.
    Seki S; Kitada T; Sakaguchi H; Hirohashi K; Kinoshita H
    Am J Gastroenterol; 2002 Aug; 97(8):2146-7. PubMed ID: 12190199
    [No Abstract]   [Full Text] [Related]  

  • 24. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer.
    Yoshimatsu K; Golijanin D; Paty PB; Soslow RA; Jakobsson PJ; DeLellis RA; Subbaramaiah K; Dannenberg AJ
    Clin Cancer Res; 2001 Dec; 7(12):3971-6. PubMed ID: 11751489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COX-2 inhibition in clinical cancer prevention.
    Lynch PM
    Oncology (Williston Park); 2001 Mar; 15(3 Suppl 5):21-6. PubMed ID: 11301836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis.
    Wu AW; Gu J; Ji JF; Li ZF; Xu GW
    World J Gastroenterol; 2003 Sep; 9(9):1990-4. PubMed ID: 12970891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer and non-steroidal anti-inflammatory drugs.
    Ota S; Bamba H; Kato A
    Acta Pharmacol Sin; 2000 May; 21(5):391-5. PubMed ID: 11324434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-2 and c-erbB-2 expression in colorectal carcinoma assessed using tissue microarrays.
    Kim JY; Lim SJ; Park K
    Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):67-70. PubMed ID: 15163022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase-2 overexpression in colorectal cancer is associated with non-polypoid growth.
    Tsunozaki H; Yoshinaga K; Kumagai J; Sugihara K
    Jpn J Clin Oncol; 2002 May; 32(5):167-71. PubMed ID: 12110643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients.
    Kennedy BP; Soravia C; Moffat J; Xia L; Hiruki T; Collins S; Gallinger S; Bapat B
    Cancer Res; 1998 Feb; 58(3):500-3. PubMed ID: 9458096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase-2 is overexpressed in serrated adenoma of the colorectum.
    Arao J; Sano Y; Fujii T; Kato S; Fu KI; Yoshino T; Ochiai A; Fujimori T; Yoshida S
    Dis Colon Rectum; 2001 Sep; 44(9):1319-23. PubMed ID: 11584208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence.
    Hao XP; Ilyas M; Talbot IC
    Pathobiology; 1997; 65(3):140-5. PubMed ID: 9309780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of cyclooxygenase-2 in macrophages of human colonic adenoma.
    Bamba H; Ota S; Kato A; Adachi A; Itoyama S; Matsuzaki F
    Int J Cancer; 1999 Nov; 83(4):470-5. PubMed ID: 10508481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer.
    Sakuma K; Fujimori T; Hirabayashi K; Terano A
    J Gastroenterol; 1999 Apr; 34(2):189-94. PubMed ID: 10213117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas.
    Uefuji K; Ichikura T; Mochizuki H
    J Surg Oncol; 2001 Jan; 76(1):26-30. PubMed ID: 11223821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas.
    Lakis S; Papamitsou T; Panagiotopoulou C; Kotakidou R; Kotoula V
    World J Gastroenterol; 2010 May; 16(20):2476-83. PubMed ID: 20503447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical characteristics of duodenal adenomas in familial adenomatous polyposis with special reference to cell kinetics.
    Esaki M; Matsumoto T; Yao S; Nakamura S; Hirahashi M; Yao T; Iida M
    Hum Pathol; 2005 Jan; 36(1):66-73. PubMed ID: 15712184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.